http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010000282-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9d212083c297d5c75d3b97ac90a50f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_caedb16f24c68b18d8102c47b30147d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c0f564bd877a79bf54d6fd2c2ddad0e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-66
filingDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ed5b379410ad268b5e7b157b5382a6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd33871bc6d8f5bd2a42be44c6485c9e
publicationDate 2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010000282-A1
titleOfInvention Method for producing n-phenyl-n-(4-piperidinyl)amide salts
abstract The invention relates to a method for producing N-phenyl-N-(4-piperidinyl)amide salts, particularly pharmaceutically tolerable addition salts of the compound Remifentanil, in that a compound of the formula (III) is reacted with an acrylic acid alkyl ester of the formula CH2=CH-C(O)-OR: where independently of each other R denotes low-molecular alkyl, preferably (C1-4)alkyl, preferably methyl or ethyl, R1 denotes low-molecular alkyl, preferably (C1-4)alkyl, preferably methyl or ethyl; and HX denotes an inorganic or organic acid, wherein the components are optionally reacted in the presence of a catalyst, preferably at a higher temperature, thereby obtaining the salt of the compound of formula (I).
priorityDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008045192-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0383579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007144391-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247861517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127690392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2800811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245597810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227182281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129954253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247990553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID242746603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127534090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129753389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243266454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247678542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89982

Total number of triples: 46.